Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
ProThera Biologics
company
About
ProThera Biologics focuses on unmet medical needs by developing integrated theranostic and therapeutic biomolecules.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $750K
- Industries
- Biotechnology,Clinical Trials,Health Care,Therapeutics
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
ProThera Biologics was established in the state of Rhode Island in 2001 by Yow-Pin Lim, MD/PhD, Assistant Professor of Medicine, Brown Medical School and Douglas C. Hixson, PhD, Professor of Medicine and Pathology/ Laboratory Medicine, Brown Medical School. Both co-founders are actively engaged in the biomedical research in the Carcinogenesis Laboratory at Rhode Island Hospital, where Dr. Hixson is the longstanding Research Director and Dr. Lim is a Research Oncologist.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$750K
ProThera Biologics has raised a total of
$750K
in funding over 2 rounds. Their latest funding was raised on
Sep 5, 2012 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 5, 2012 | Series Unknown | $750K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
ProThera Biologics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
